Contravisory Investment Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-16,148
Closed -$844K 438
2026
Q1
$844K Buy
16,148
+14,896
+1,190% +$894K 0.17% 103
2025
Q4
$73.6K Buy
+1,252
New +$76.1K 0.01% 267
2024
Q4
Sell
-5,862
Closed -$469K 428
2024
Q3
$469K Buy
+5,862
New +$440K 0.1% 148
2022
Q1
Sell
-4,776
Closed -$618K 376
2021
Q4
$618K Buy
4,776
+1,724
+56% +$211K 0.17% 83
2021
Q3
$370K Hold
3,052
0.11% 131
2021
Q2
$344K Hold
3,052
0.1% 139
2021
Q1
$291K Hold
3,052
0.09% 138
2020
Q4
$242K Sell
3,052
-336
-10% -$24.3K 0.08% 146
2020
Q3
$210K Hold
3,388
0.07% 146
2020
Q2
$212K Buy
3,388
+188
+6% +$11.3K 0.08% 144
2020
Q1
$152K Sell
3,200
-140
-4% -$7K 0.07% 145
2019
Q4
$183K Hold
3,340
0.07% 147
2019
Q3
$163K Sell
3,340
-144
-4% -$7.22K 0.06% 147
2019
Q2
$182K Hold
3,484
0.07% 142
2019
Q1
$173K Sell
3,484
-456
-12% -$20.5K 0.07% 146
2018
Q4
$143K Buy
3,940
+252
+7% +$10.5K 0.06% 150
2018
Q3
$188K Hold
3,688
0.07% 146
2018
Q2
$136K Buy
3,688
+3,592
+3,742% +$137K 0.05% 179
2018
Q1
$4K Hold
96
﹤0.01% 310
2017
Q4
$3K Hold
96
﹤0.01% 317
2017
Q3
$3K Buy
+96
New +$2.85K ﹤0.01% 341
2015
Q1
Sell
-96
Closed -$2K 181
2014
Q4
$2K Hold
96
﹤0.01% 156
2014
Q3
$2K Hold
96
﹤0.01% 145
2014
Q2
$2K Sell
96
-96
-50% -$2.12K ﹤0.01% 144
2014
Q1
$4K Hold
192
﹤0.01% 142
2013
Q4
$5K Hold
192
﹤0.01% 115
2013
Q3
$4K Hold
192
﹤0.01% 110
2013
Q2
$3K Buy
+192
New +$3.19K ﹤0.01% 118

Other funds holding TECH

Contravisory Investment Management's TECH Position: Q2 2026 in Review

Contravisory Investment Management sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 16,148 shares — an estimated $844K sold.

Contravisory Investment Management first reported a position in TECH in Q2 2013 and held it in 28 quarters. The position peaked at $844K in Q1 2026. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Contravisory Investment Management reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Contravisory Investment Management sold 16,148 Bio-Techne shares in Q2 2026, an estimated $844K.
  • Contravisory Investment Management first reported a position in Bio-Techne in Q2 2013 and held it in 28 quarters.
  • Contravisory Investment Management's Bio-Techne position peaked at $844K in Q1 2026.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.